These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24521628)

  • 1. Role of secretory phospholipase A₂ in women with metabolic syndrome.
    Pop D; Sitar-Taut A; Bodisz G; Zdrenghea D; Cebanu M; Stanca L
    Indian J Med Res; 2013 Dec; 138(6):866-72. PubMed ID: 24521628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia.
    Braamskamp MJ; Tsimikas S; Wiegman A; Kastelein JJ; Hutten BA
    Atherosclerosis; 2013 Aug; 229(2):404-7. PubMed ID: 23880195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is lipoprotein-associated phospholipase A₂ correlated with cardiovascular risk in European women?
    Hirschler V
    Indian J Med Res; 2013 Dec; 138(6):832-3. PubMed ID: 24521623
    [No Abstract]   [Full Text] [Related]  

  • 4. Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort.
    Chung O; Juonala M; Mallat Z; Hutri-Kähönen N; Viikari JSA; Raitakari OT; Magnussen CG
    J Pediatr (Rio J); 2019; 95(2):247-254. PubMed ID: 29476705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
    Mattsson N; Magnussen CG; Rönnemaa T; Mallat Z; Benessiano J; Jula A; Taittonen L; Kähönen M; Juonala M; Viikari JS; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1861-6. PubMed ID: 20539018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
    Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
    Holmes MV; Simon T; Exeter HJ; Folkersen L; Asselbergs FW; Guardiola M; Cooper JA; Palmen J; Hubacek JA; Carruthers KF; Horne BD; Brunisholz KD; Mega JL; van Iperen EPA; Li M; Leusink M; Trompet S; Verschuren JJW; Hovingh GK; Dehghan A; Nelson CP; Kotti S; Danchin N; Scholz M; Haase CL; Rothenbacher D; Swerdlow DI; Kuchenbaecker KB; Staines-Urias E; Goel A; van 't Hooft F; Gertow K; de Faire U; Panayiotou AG; Tremoli E; Baldassarre D; Veglia F; Holdt LM; Beutner F; Gansevoort RT; Navis GJ; Mateo Leach I; Breitling LP; Brenner H; Thiery J; Dallmeier D; Franco-Cereceda A; Boer JMA; Stephens JW; Hofker MH; Tedgui A; Hofman A; Uitterlinden AG; Adamkova V; Pitha J; Onland-Moret NC; Cramer MJ; Nathoe HM; Spiering W; Klungel OH; Kumari M; Whincup PH; Morrow DA; Braund PS; Hall AS; Olsson AG; Doevendans PA; Trip MD; Tobin MD; Hamsten A; Watkins H; Koenig W; Nicolaides AN; Teupser D; Day INM; Carlquist JF; Gaunt TR; Ford I; Sattar N; Tsimikas S; Schwartz GG; Lawlor DA; Morris RW; Sandhu MS; Poledne R; Maitland-van der Zee AH; Khaw KT; Keating BJ; van der Harst P; Price JF; Mehta SR; Yusuf S; Witteman JCM; Franco OH; Jukema JW; de Knijff P; Tybjaerg-Hansen A; Rader DJ; Farrall M; Samani NJ; Kivimaki M; Fox KAA; Humphries SE; Anderson JL; Boekholdt SM; Palmer TM; Eriksson P; Paré G; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
    J Am Coll Cardiol; 2013 Nov; 62(21):1966-1976. PubMed ID: 23916927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
    Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
    Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group IIA Secretory Phospholipase A
    Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.
    Moutzouri E; Tsimihodimos V; Tselepis AD
    Curr Pharm Des; 2013; 19(21):3827-40. PubMed ID: 23286437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
    Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
    Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration.
    Misso NL; Petrovic N; Grove C; Celenza A; Brooks-Wildhaber J; Thompson PJ
    Thorax; 2008 Jan; 63(1):21-6. PubMed ID: 17573441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
    Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory phospholipase A2 activity in blood serum: the challenge to sense.
    Alekseeva AS; Korotaeva AA; Samoilova EV; Volynsky PE; Vodovozova EL; Boldyrev IA
    Biochem Biophys Res Commun; 2014 Nov; 454(1):178-82. PubMed ID: 25450377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo, and in vivo.
    Autilio C; Shankar-Aguilera S; Minucci A; Touqui L; De Luca D
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L498-L505. PubMed ID: 30604626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
    Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
    Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Secretory Phospholipase A2 Activity following Snakebites and Its Relationship with Envenomation Status and Progression of Local Swelling.
    Bhardwaj A; Muthu R; Soundravally R; Pillai AB; Bammigatti C; Kadhiravan T
    Am J Trop Med Hyg; 2020 Dec; 104(3):1142-1148. PubMed ID: 33319738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A2 in patients with coronary artery disease.
    Lima LM; Carvalho Md; da Fonseca Neto CP; Garcia JC; Sousa MO
    J Thromb Thrombolysis; 2010 Apr; 29(3):276-81. PubMed ID: 19449149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.